{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "10683007", "DateCompleted": {"Year": "2000", "Month": "03", "Day": "02"}, "DateRevised": {"Year": "2015", "Month": "06", "Day": "16"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0140-6736", "JournalIssue": {"Volume": "355", "Issue": "9203", "PubDate": {"Year": "2000", "Month": "Feb", "Day": "12"}}, "Title": "Lancet (London, England)", "ISOAbbreviation": "Lancet"}, "ArticleTitle": "Indinavir concentrations and St John's wort.", "Pagination": {"StartPage": "547", "EndPage": "548", "MedlinePgn": "547-8"}, "Abstract": {"AbstractText": ["St John's wort reduced the area under the curve of the HIV-1 protease inhibitor indinavir by a mean of 57% (SD 19) and decreased the extrapolated 8-h indinavir trough by 81% (16) in healthy volunteers. A reduction in indinavir exposure of this magnitude could lead to the development of drug resistance and treatment failure."]}, "AuthorList": [{"AffiliationInfo": [], "Identifier": [], "LastName": "Piscitelli", "ForeName": "S C", "Initials": "SC"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Burstein", "ForeName": "A H", "Initials": "AH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Chaitt", "ForeName": "D", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Alfaro", "ForeName": "R M", "Initials": "RM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Falloon", "ForeName": "J", "Initials": "J"}], "PublicationTypeList": ["Clinical Trial", "Letter"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Lancet", "NlmUniqueID": "2985213R", "ISSNLinking": "0140-6736"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "HIV Protease Inhibitors"}, {"RegistryNumber": "5W6YA9PKKH", "NameOfSubstance": "Indinavir"}], "CommentsCorrectionsList": [{"RefSource": "Lancet 2001 Apr 14;357(9263):1210"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Oral"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Area Under Curve"}, {"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": [], "DescriptorName": "Drug Resistance"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["administration & dosage", "antagonists & inhibitors", "pharmacokinetics"], "DescriptorName": "HIV Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Hypericum"}, {"QualifierName": ["administration & dosage", "antagonists & inhibitors", "pharmacokinetics"], "DescriptorName": "Indinavir"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Middle Aged"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Treatment Failure"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2000", "Month": "2", "Day": "22", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "3", "Day": "4", "Hour": "9", "Minute": "0"}, {"Year": "2000", "Month": "2", "Day": "22", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["10683007", "10.1016/S0140-6736(99)05712-8", "S0140-6736(99)05712-8"]}}], "PubmedBookArticle": []}